Mergers & Acquisitions


Current filters:


Popular Filters

676 to 700 of 919 results

WuXi PharmaTech sets up clinical trials JV with PRA


Chinese contract research organization WuXi PharmaTech (NYSE: WX) and PRA, a global clinical CRO, have…

Asia-PacificMergers & AcquisitionsPharmaceuticalResearchWuXi PharmaTech

DCC Healthcare acquires generic drugmaker Kent Pharma


Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that…

Antibiotics and Infectious diseasesDCC HealthcareGenericsKent PharmaceuticalMergers & Acquisitions

Norgine and SpePharm set up JV to commercialize portfolio of drugs


Independent Dutch firm Norgine BV and fellow Amsterdam-based SpePharm Holding BV have concluded a broad…

Markets & MarketingMergers & AcquisitionsNorginePharmaceuticalSpePharma

No "Japan pharma for sale signs," by P Reed Maurer


Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

Vivalis and Intercell announce "merger of equals"


French biotech firm Vivalis (Euronext: VLS) has entered into an accord to acquire Intercell (ICEL.VI)…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Enzon mulls sale of company; Bio-Rad to acquire business from MorphoSys


USA-based Enzon Pharmaceuticals (Nasdaq: ENZN) said yesterday that its board has retained Lazard to act…

Bio-Rad LaboratoriesBiotechnologyEnzon PharmaceuticalsMergers & AcquisitionsMorphoSys

Fresenius Kabi sells respiratory homecare business in France


Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Recordati buys US portfolio of drugs from Lundbeck


Italian drugmaker Recordati *RC: MI) has signed an agreement for the acquisition of all rights concerning…

LundbeckMergers & AcquisitionsNorth AmericaPharmaceuticalRare diseasesRecordati

Kemira sells ChemSolutions' food and pharma businesses to Niacet


Finland-based water chemistry specialist Kemira Oyj (OMX: KRA1V) has signed an agreement to sell its…

GenericsKemiraMergers & AcquisitionsNiacet

Bausch & Lomb said to be on the block for $10 billion


A Bloomberg report says that Warburg Pincus, which acquired the business in 2007, has appointed Goldman…

Bausch & LombMergers & AcquisitionsOphthalmicsPharmaceutical

Gilead agrees to buy YM BioSciences for $510 million


US biotech firm Gilead Sciences (Nasdaq: GILD) has agreed to acquire Canada's YM BioSciences (TSX: YM)…

BiotechnologyCYT387Gilead SciencesMergers & AcquisitionsOncologyPharmaceuticalYM Biosciences

Pernix Thera rescues struggling Somaxon with stock deal worth $25 million


Troubled US drugmaker Somaxon Pharmaceuticals (Nasdaq: SOMX) saw its shares leap around 85% to $2.74…

Mergers & AcquisitionsPernix TherapeuticsPharmaceuticalSilenorSomaxon Pharmaceuticals

Amgen paying $415 to acquire deCODE Genetics


In what has been a busy M&A period for US biotech giant Amgen (Nasdaq: AMGN), the company has entered…

AmgenBiotechnologydeCODE GeneticsMergers & AcquisitionsPharmaceutical

Claris Lifesciences dips on sale of infusions business


Indian drugmaker Claris Lifesciences (CLAI: BO) has dipped 4% to 264 rupees, declining over 6% from day's…

Asia-PacificClaris LifesciencesMergers & AcquisitionsMitsui & CoOtsukaPharmaceutical

Baxter to expand renal therapies range with $4 billion buy of Gambro


Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered…

Baxter InternationalGambroMergers & AcquisitionsNephrology and HepatologyPharmaceutical

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva


Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

XTL Biopharma buys Teva's stake in Proteologics


In a second M&A deal this year, Israel's XTL Biopharmaceuticals (TASE: XTL) announced that it has acquired…

Mergers & AcquisitionsPharmaceuticalProteologicsTeva Pharmaceutical IndustriesXTL Biopharmaceuticals

676 to 700 of 919 results

Back to top